Author

Xiaoting Wang

Alector (United States)ORCID 0000-0003-4367-5836Unclaimed ORCID profile · follow to get notified of new preprints

Additional preprints under this name without ORCID

Xiaoting Wang1 paper · Liaocheng University

Biology Disciplines

Click to filter author papers

Bioinformatics· 1 Systems Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 2 Assay:bulk RNA-seq· 1 Research Focus:drug response / drug discovery· 1 Research Focus:gene regulatory network inference· 1 Approach:large language model· 1 Approach:machine learning (classical)· 1 Assay:proteomics· 1

Frequent Co-Authors

Alexander Moreno· 1 shared Chengliang Hu· 1 shared Chunhao YangiD· 1 shared Dan Yang ZhaoiD· 1 shared Enming YuaniD· 1 shared Fang WaniD· 1 shared Fengcai ZhuiD· 1 shared Hainian Zeng· 1 shared

Activity by Year

2021-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 36 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperBioinformatics

Alexander Moreno

Author profile →

2 papers

Recent·Most cited

BioinformaticsBioinformatics AdvancesPeer-reviewedDec 26, 2024

Enhancing Gene Set Overrepresentation Analysis with Large Language Models

Jiqing Zhu, Rebecca Y. Wang, Xiaoting Wang…·Zia Khan

This paper introduces llm2geneset, a framework using large language models to generate gene sets from input genes and context, improving overrepresentation analysis compared to human-curated databases.

8 citations

humanbulk RNA-seq

Systems BiologySignal Transduction and Targeted TherapyPeer-reviewedApr 24, 2021

A data-driven drug repositioning framework discovered a potential therapeutic agent targeting COVID-19

Yiyue Ge, Tingzhong Tian, Suling Huang…·Jianyang Zeng

This paper presents a data-driven drug repositioning framework that identifies CVL218, a PARP1 inhibitor, as a potential therapeutic for COVID-19 through in silico and experimental validation.

300 citationstop 1%

humanmachine learning (classical)